5 results  1 of 1 

1 Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)
Yoon Ji Choi, Hye Sook Kim, Se Hoon Park, Bong-Seog Kim, Kyoung Ha Kim, Hyo Jin Lee, Hong Suk Song, Dong-Yeop Shin, Ha Young Lee, Hoon-Gu Kim, Kyung Hee Lee, Jae Lyun Lee, Kyong Hwa Park
Cancer Res Treat.2018;50(4):1252-1259.   Published online 2018 January 2     DOI: http://dx.doi.org/10.4143/crt.2017.438
      
2 The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients
Choung-Soo Kim, Ad Theeuwes, Dong Deuk Kwon, Young Deuk Choi, Byung Ha Chung, Hyun Moo Lee, Kang Hyun Lee, Sang Eun Lee
Investig Clin Urol.2016;57(3):174-183.   Published online 2016 May 10     DOI: http://dx.doi.org/10.4111/icu.2016.57.3.174
      
3 The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
Ja Yoon Ku, Jeong Zoo Lee, Hong Koo Ha
Korean J Urol.2015;56(10):689-694.   Published online 2015 October 13     DOI: http://dx.doi.org/10.4111/kju.2015.56.10.689
      
4 Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer
Jaeyoon Jung, Chunwoo Lee, Chanwoo Lee, Taekmin Kwon, Dalsan You, In Gab Jeong, Jun Hyuk Hong, Hanjong Ahn, Choung-Soo Kim
Korean J Urol.2015;56(9):630-636.   Published online 2015 September 2     DOI: http://dx.doi.org/10.4111/kju.2015.56.9.630
      
5 Nonmetastatic Castration-Resistant Prostate Cancer
Jun Hyuk Hong, Isaac Y. Kim
Korean J Urol.2014;55(3):153-160.   Published online 2014 March 13     DOI: http://dx.doi.org/10.4111/kju.2014.55.3.153
      

 1 of 1